N/A Completed N=100 Diagnostic

Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy

Barrett's esophagus

Source: ClinicalTrials.gov NCT02066233 ↗

Enrolled (actual)

100

Serious AEs

0.0%

Results posted

Jul 2017

Primary outcomePrimary: Median Tolerability Score on 10-point Visual Analog Scale (VAS) — 7; 8; 8; 8 units on a scale

Summary

The purpose of this study was to evaluate whether a disposable nasal endoscope called "E.G. Scan II" will visualize the esophagus as well as the standard test, sedated endoscopy.

Outcome Measures

Outcome	Result	p-value
PRIMARY Median Tolerability Score on 10-point Visual Analog Scale (VAS)	7; 8; 8; 8	—
SECONDARY Preference for Either of the Two Procedures, EG II Scan Versus Standard Endoscopy	21; 18; 4; 11; 17; 15	—

Eligibility Criteria

Inclusion Criteria

Adult participants aged 18 years or above who are scheduled for routine upper GI endoscopy for Barrett's Esophagus surveillance, varices surveillance and dyspepsia.
Able and willing to give informed consent.

Exclusion Criteria

Patients known to be intolerant to endoscopy.
Patients with frequent epistaxis.
Patients not clinically fit for endoscopy as judged by their care team.
Pregnant women.
Patients with allergy/sensitivity to Simethicone (Mylicon), Phenylephrine, Lidocaine nasal spray, Benzocaine spray (Topex)
Use of anticoagulants or antiplatelets.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02066233). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.